Literature DB >> 15309737

Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.

Jian-Guo Qiao1, Yu-Qing Zhang, Yu-Chun Yin, Zui Tan.   

Abstract

AIM: To investigate the expression of Survivin in pancreatic cancer and its correlation to the expression of Bcl-2.
METHODS: Survivin and Bcl-2 expressions were examined by immunohistochemistry in 42 tissue samples from pancreatic cancer and 10 from normal pancrease.
RESULTS: No survivin expression was detected in the tissue samples from normal pancrease, while it was detected in 34 of 42 tissue samples from pancreatic cancer (81.95%). There was a correlation between survivin expression and differentiation and stages of pancreatic cancer. Survivin positive cases were strongly correlated to Bcl-2 expression (28/30 vs 6/12, P<0.05).
CONCLUSION: Overexpression of survivin plays an important role in the development and progression of pancreatic cancer, and correlates to the expression of Bcl-2. Survivin expression can be used as a prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309737      PMCID: PMC4572211          DOI: 10.3748/wjg.v10.i18.2759

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Urine detection of survivin and diagnosis of bladder cancer.

Authors:  M Moore
Journal:  J Insur Med       Date:  2001

2.  Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.

Authors:  Derek A Hausladen; Marcia A Wheeler; Dario C Altieri; John W Colberg; Robert M Weiss
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

Review 3.  Survivin study: what is the next wave?

Authors:  Fengzhi Li
Journal:  J Cell Physiol       Date:  2003-10       Impact factor: 6.384

4.  Proliferative activity and apoptosis in thymic epithelial neoplasms.

Authors:  Kenzo Hiroshima; Akira Iyoda; Tetsuya Toyozaki; Yana Supriatna; Kiyoshi Shibuya; Fumihiko Shimamura; Yukiko Haga; Shigetoshi Yoshida; Takehiko Fujisawa; Hidemi Ohwada
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

5.  Survivin promotes cell proliferation in human hepatocellular carcinoma.

Authors:  T Ito; K Shiraki; K Sugimoto; T Yamanaka; K Fujikawa; M Ito; K Takase; M Moriyama; H Kawano; M Hayashida; T Nakano; A Suzuki
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

Review 6.  [Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence].

Authors:  B Sela
Journal:  Harefuah       Date:  2002-01

7.  Targeting Survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells.

Authors:  Bing Z Carter; Rui-Yu Wang; Wendy D Schober; Michele Milella; David Chism; Michael Andreeff
Journal:  Cell Cycle       Date:  2003 Sep-Oct       Impact factor: 4.534

8.  Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Authors:  Juan F García; Francisca I Camacho; Manuel Morente; Máximo Fraga; Carlos Montalbán; Tomás Alvaro; Carmen Bellas; Angel Castaño; Ana Díez; Teresa Flores; Carmen Martin; Miguel A Martinez; Francisco Mazorra; Javier Menárguez; Maria J Mestre; Manuela Mollejo; Ana I Sáez; Lydia Sánchez; Miguel A Piris
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

9.  Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma.

Authors:  A I Sarela; C S Verbeke; J Ramsdale; C L Davies; A F Markham; P J Guillou
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

10.  A role for survivin in radioresistance of pancreatic cancer cells.

Authors:  Koichi Asanuma; Daisuke Kobayashi; Daisuke Furuya; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Jpn J Cancer Res       Date:  2002-09
View more
  9 in total

Review 1.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 2.  Potential targets for pancreatic cancer immunotherapeutics.

Authors:  Lindzy F Dodson; William G Hawkins; Peter Goedegebuure
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

3.  Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.

Authors:  Felix Rückert; Nicole Samm; Anne-Kathrin Lehner; Hans-Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  BMC Cancer       Date:  2010-07-20       Impact factor: 4.430

4.  Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.

Authors:  Klaus L Prenzel; Ute Warnecke-Eberz; Jan Brabender; Stephan E Baldus; Elfriede Bollschweiler; Christian A Gutschow; Uta Drebber; Arnulf H Hoelscher; Paul M Schneider
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.

Authors:  Praveen Bhoopathi; Bridget A Quinn; Qin Gui; Xue-Ning Shen; Steven R Grossman; Swadesh K Das; Devanand Sarkar; Paul B Fisher; Luni Emdad
Journal:  Cancer Res       Date:  2014-09-09       Impact factor: 12.701

6.  YM155 induces EGFR suppression in pancreatic cancer cells.

Authors:  Young-Soon Na; Soo-Jin Yang; Seung-Mi Kim; Kyung-Ah Jung; Jai-Hee Moon; Jae-Sik Shin; Dok Hyun Yoon; Yong Sang Hong; Min-Hee Ryu; Jae-Lyun Lee; Jung Shin Lee; Tae Won Kim
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.752

7.  Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

Authors:  Shikhar Mehrotra; Carolyn D Britten; Steve Chin; Elizabeth Garrett-Mayer; Colleen A Cloud; Mingli Li; Gina Scurti; Mohamed L Salem; Michelle H Nelson; Melanie B Thomas; Chrystal M Paulos; Andres M Salazar; Michael I Nishimura; Mark P Rubinstein; Zihai Li; David J Cole
Journal:  J Hematol Oncol       Date:  2017-04-07       Impact factor: 17.388

8.  Network analysis reveals rare disease signatures across multiple levels of biological organization.

Authors:  Pisanu Buphamalai; Tomislav Kokotovic; Vanja Nagy; Jörg Menche
Journal:  Nat Commun       Date:  2021-11-09       Impact factor: 14.919

Review 9.  Apoptotic pathways in pancreatic ductal adenocarcinoma.

Authors:  Rainer Hamacher; Roland M Schmid; Dieter Saur; Günter Schneider
Journal:  Mol Cancer       Date:  2008-07-24       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.